CLINICAL_TRIALS ClinicalTrials.gov record update

Study Comparing the Immunogenicity and Reactogenicity of Different Formulations of GSK Bio's HBV-MPL Vaccine Injected as a 0, 6 Months Schedule With That of Engerix™-B Injected as a 0, 1, 6 Months Schedule in Healthy Adults Aged 18-40 Years

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00698555
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:34:55.095369+00:00
Published At: 2008-06-17T00:00:00+00:00
Record Updated At: 2008-06-17
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Hepatitis B"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2008-06-17"
protocolSection.identificationModule.nctId: "NCT00698555"
protocolSection.identificationModule.officialTitle: "Study Comparing the Immunogenicity and Reactogenicity of Different Formulations of GSK Bio\u0027s HBV-MPL Vaccine Injected as a 0, 6 Months Schedule With That of Engerix\u2122-B Injected as a 0, 1, 6 Months Schedule in Healthy Adults Aged 18-40 Years"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.